Truist Maintains Hold Rating on Medtronic (MDT), Citing Need for Stronger EPS Growth

Truist analysts have reiterated a 'Hold' rating on Medtronic (MDT) stock, indicating that the company needs to demonstrate stronger earnings per share growth to warrant a more positive outlook.